Last reviewed · How we verify
vaccinate with DT
DT vaccine stimulates the immune system to produce antibodies against diphtheria and tetanus toxins, providing protective immunity against these bacterial diseases.
DT vaccine stimulates the immune system to produce antibodies against diphtheria and tetanus toxins, providing protective immunity against these bacterial diseases. Used for Prevention of diphtheria, Prevention of tetanus.
At a glance
| Generic name | vaccinate with DT |
|---|---|
| Sponsor | Zhejiang Provincial Center for Disease Control and Prevention |
| Drug class | Vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology / Infectious Disease Prevention |
| Phase | FDA-approved |
Mechanism of action
The DT vaccine contains inactivated diphtheria and tetanus toxoids (toxins rendered harmless), which trigger the adaptive immune response to generate antibodies and memory cells. Upon exposure to wild-type Corynebacterium diphtheriae or Clostridium tetani, these pre-formed antibodies neutralize the bacterial toxins before they can cause systemic disease. This is a toxoid-based immunization strategy that has been standard public health practice for decades.
Approved indications
- Prevention of diphtheria
- Prevention of tetanus
Common side effects
- Injection site pain, redness, or swelling
- Fever
- Myalgia
- Fatigue
Key clinical trials
- Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children (PHASE4)
- Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT ) (PHASE4)
- Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- vaccinate with DT CI brief — competitive landscape report
- vaccinate with DT updates RSS · CI watch RSS
- Zhejiang Provincial Center for Disease Control and Prevention portfolio CI